Guidelines Presented for Fluoroquinolone Use in Children

Share this content:
Guidelines Presented for Fluoroquinolone Use in Children
Guidelines Presented for Fluoroquinolone Use in Children

MONDAY, Oct. 31, 2016 (HealthDay News) -- In a clinical report published online Oct. 31 in Pediatrics, guidelines are presented for the use of systemic and topical fluoroquinolones in children.

Mary Anne Jackson, M.D., and colleagues from the American Academy of Pediatrics Committee on Infectious Diseases discuss the use of systemic and topical fluoroquinolones in children.

The researchers note that fluoroquinolones are broad-spectrum agents which should be considered for use in specific situations. These include infection caused by a multidrug-resistant pathogen for which there is no alternative that is safe and effective, and for situations in which oral fluoroquinolone therapy is an acceptable alternative to parenteral non-fluoroquinolone therapy. Fluoroquinolones may also represent a preferred option or an acceptable alternative to standard therapy due to concerns of antimicrobial resistance, toxicity, or tissue penetration characteristics.

"In the case of fluoroquinolones, as is appropriate with all antimicrobial agents, prescribing clinicians should verbally review common, anticipated, potential adverse events, such as rash, diarrhea, and potential musculoskeletal or neurologic events and indicate why a fluoroquinolone is the most appropriate antibiotic agent for a child's infection," the authors write.

Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Kinase Inhibitor for Treatment of AML

FDA Approves Kinase Inhibitor for Treatment of AML

Midostaurin, in combination with chemotherapy, treats acute myeloid leukemia in adults

Enzyme Replacement Drug OK'd for Form of Batten Disease

Enzyme Replacement Drug OK'd for Form of Batten ...

Brineura will be used to treat children with late infantile neuronal ceroid lipofuscinosis type 2 Batten

is free, fast, and customized just for you!

Already a member?

Sign In Now »